Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01151228
Other study ID # 09-0764-BE
Secondary ID
Status Completed
Phase N/A
First received June 24, 2010
Last updated February 8, 2013
Start date December 2009
Est. completion date September 2011

Study information

Verified date February 2013
Source University Health Network, Toronto
Contact n/a
Is FDA regulated No
Health authority Canada: Research Ethics Board
Study type Interventional

Clinical Trial Summary

Patients undergoing gastroscopy will undergo two pre-procedure ultrasound scans of the stomach, once on arrival in the unit and on an empty stomach and a second time after consumption of a randomized amount of apple juice (0, 50, 100, 200, 300 or 400 mL). Immediately after ingestion and the second ultrasound scan, subjects will have their gastroscopy which will start by suctioning out the apple juice. Measurements of stomach fluid volume conducted by ultrasound will be compared to the actual volume removed during the gastroscopy procedure.


Recruitment information / eligibility

Status Completed
Enrollment 108
Est. completion date September 2011
Est. primary completion date August 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Age 18-80 years

- Weight 50-100 kg

- height greater than 150 cm

- ability to provide informed consent

Exclusion Criteria:

- recent upper GI bleed (within 1 month)

- previous lower esophageal or gastric surgery

- not fasted for 8 hours

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor)


Related Conditions & MeSH terms


Intervention

Other:
Ultrasound examination followed by ingestion of Apple Juice prior to a second ultrasound procedure, followed by gastroscopic suctioning of stomach content.
Ultrasound scan of the stomach followed by ingestion of 0, 50, 100, 200, 300, or 400 mL of apple juice, followed by second ultrasound scan of the stomach, followed by gastroscopic suctioning of stomach content.

Locations

Country Name City State
Canada Toronto Western Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stomach volume Fluid volume in the stomach after ingestion of apple juice will be compared between measurements done with ultrasound vs direct suctioning of fluid from the stomach. 1 hour No
See also
  Status Clinical Trial Phase
Completed NCT01350050 - Topical Pharyngeal Anesthesia With Articaine for Gastroscopy Phase 4
Completed NCT04292496 - Anastomotic Leak Testing in Gastrectomy N/A
Completed NCT05219136 - Improve the Comfort, Safety and Quality of Upper Endoscopy by a Modified Fasting Protocol N/A
Completed NCT04150237 - Using Simulation to Ensure Basic Competence in Gastroscopy
Completed NCT05012527 - Retrospective Review of Gastrointestinal System Endoscopy Procedures
Completed NCT05504434 - Performance of a Single-use Gastroscope (aScope Gastro) for Esophagogastroduodenoscopy N/A
Recruiting NCT05965921 - Real-life Prospective Evaluation of Computer-aided Detection (CAD) of Barrett's Neoplasia
Completed NCT02576340 - Spasmolytic in Upper Gastrointestinal Endoscopy Phase 4
Completed NCT01154530 - Chlorhexidine Mouthwash and Bacterial Contamination During Endoscopy N/A
Completed NCT05773807 - Effect of Bispectral Index Monitoring (BIS) on Body Movement of Outpatients Undergoing Gastroscopy N/A
Completed NCT04247399 - Simulation-assisted Teaching in Learning Gastroscopy N/A
Not yet recruiting NCT05693298 - High Flow Nasal Cannula in Patients Undergoing Gastroscopy N/A
Completed NCT04682821 - The Research of AI Assistant Gastroscope Training N/A
Recruiting NCT04641455 - Use of Mucolytic Solution Before Upper Endoscopy N/A
Not yet recruiting NCT06303037 - Effect of Esketamine on 95% Induction Dose of Remimazolam Phase 4